Assets Cambiamento Data
AbbVie USD 136.22B 854M 2023-09
Acorda Therapeutics USD 364.7M 10.21M 2023-06
Amgen USD 97.15B 6.62B 2023-12
Arrowhead Research USD 626.29M 139.27M 2023-12
AstraZeneca USD 96.09B 457M 2023-09
BioCryst Pharmaceuticals USD 522.92M 6.96M 2023-09
Biogen USD 26.84B 1.35B 2023-12
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Enanta Pharmaceuticals USD 462.28M 32.89M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Heron Therapeutics USD 229.2M 27.98M 2023-09
Immunic USD 66.98M 21.76M 2023-09
Incyte USD 6.78B 393.87M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
J&J USD 166.06B 25.62B 2023-09
Ligand Pharmaceuticals USD 787.22M 17.99M 2023-12
Marinus Pharmaceuticals USD 200.81M 394K 2023-09
Merck USD 106.73B 2.26B 2023-09
Neurocrine Biosciences USD 2.85B 235.1M 2023-09
Novavax USD 1.66B 27.89M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
PTC Therapeutics USD 1.9B 635.81M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Enanta Pharmaceuticals Attività - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.